Mirum Pharmaceuticals, Inc. (MIRM)
93.72
+0.18
(+0.19%)
USD |
NASDAQ |
Nov 06, 16:00
93.72
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Total Long Term Debt (Quarterly) : 740.97M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 740.97M |
| June 30, 2026 | 760.54M |
| March 31, 2026 | 321.43M |
| December 31, 2025 | 317.31M |
| September 30, 2025 | 316.73M |
| June 30, 2025 | 316.82M |
| March 31, 2025 | 315.51M |
| December 31, 2024 | 316.05M |
| September 30, 2024 | 316.15M |
| June 30, 2024 | 315.49M |
| March 31, 2024 | 307.16M |
| December 31, 2023 | 307.04M |
| September 30, 2023 | 306.89M |
| June 30, 2023 | 306.76M |
| March 31, 2023 | 142.76M |
| December 31, 2022 | 141.61M |
| Date | Value |
|---|---|
| September 30, 2022 | 139.33M |
| June 30, 2022 | 137.23M |
| March 31, 2022 | 134.65M |
| December 31, 2021 | 131.83M |
| September 30, 2021 | 128.36M |
| June 30, 2021 | 122.88M |
| March 31, 2021 | 53.31M |
| December 31, 2020 | 50.28M |
| September 30, 2020 | 2.788M |
| June 30, 2020 | 2.947M |
| March 31, 2020 | 3.103M |
| December 31, 2019 | 3.251M |
| September 30, 2019 | 1.124M |
| June 30, 2019 | 1.24M |
| March 31, 2019 | 1.19M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Incyte Corp. | 31.76M |
| Galectin Therapeutics, Inc. | 0.00 |
| TG Therapeutics, Inc. | 752.53M |
| Ardelyx, Inc. | 254.76M |
| Kodiak Sciences, Inc. | 142.94M |